ORIC Pharmaceuticals Inc. (NASDAQ:ORIC) changes shares on Tuesday trading session, with a change of 2.27% or $0.5 shares. The trading starts at $21.65 and closed at $22.05 throughout the day. The trading session low price was $21.3601 and day high was $22.90 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 42929.0 while its average volume is 209.62K. In other hand, the ORIC market cap reached to $706.27M.
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -4.69% and down -21.15% for month. Its quarterly performance was -21.78% below. ORIC performance fall -12.50% for year-to-date. Current recommendation for ORIC Pharmaceuticals Inc. is 1.60.
EPS for this year is -25.80%, while for the next year its value is -2.14.
Let’s take a look on the analyst recommendations on ORIC for the current month and previous month. For the current month, 5 of 6 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 1 as Hold. As compared with the previous month ratings, 5 analysts participate in stock recommendation. Out of 5, 0 rated it sell, 4 rated it as Buy and 1 as Hold Ratings. On the other hand, target price ranges from $35.00 – $52.00. Average target price for ORIC was reached at $43.83.
Matthews International Capital Management, LLC, Emerald Advisers and Emerald Mutual Fund Advisers Trust are the top three holders in ORIC Pharmaceuticals Inc. (ORIC) stock. On Jun 29, 2020, Matthews International Capital Management, LLC has 0.19 million shares which valued 6.46 million. On Jun 29, 2020, Emerald Advisers owned 0.19 million shares which valued at 6.28 million. On Jun 29, 2020, Emerald Mutual Fund Advisers Trust has a total of 0.17 million shares which valued at 5.71 million. In the end, Emerald Mutual Fund Advisers Trust have 0.61% shares outstanding of ORIC Pharmaceuticals Inc. (ORIC) on Jun 29, 2020. The insider ownership moved to 0.40% and institutional holding shifted to 63.80%.
According to the most recent quarter report on (Jun 2020), 6 analysts estimated an average EPS of -0.4. Analyst Estimated EPS for ORIC published in the report was -$0.67 – -$0.21 during the same period.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for ORIC fall -23.50% for period of 200 days. SMA for 50 days was -23.32% which is showing red signal, while SMA-20 was -4.73%. The moving average value for ORIC Pharmaceuticals Inc. (ORIC) is 2.03M and 7.19% for 200 and 50 days respectively.